entertainment -WSS

entertainment

author：entertainment 2025-09-30 00:37:27 - browse：95698

Crowd of people in the formation of a dollar sign -- health policy coverage from STAT — The finance chief of the country’s largest private psychiatric hospital operator, UHS, made a blunt statement today: The company admits patients based on whose insurance pays more. Adobe

The country’s largest private psychiatric hospital operator cherry-picks patients whose insurance will pay more, its finance chief said on an earnings call Wednesday.

It’s no secret that such hospitals, especially when run by for-profit companies, base admission decisions on how much they’ll get paid, but it’s rare to hear the practice described so bluntly. The comments came from Steve Filton, the chief financial officer of investor-owned Universal Health Services, a company that runs more than 300 behavioral health hospitals nationwide that handled just shy of 120,000 admissions in the three months that ended June 30.

UHS has been “simply admitting patients whose insurance will pay us more,” Filton said on the company’s second quarter earnings call. “In an environment where we can only treat a limited number of patients, we can be more selective about who we treat and the fairness of what we think we’re being paid.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Helping hospitals and community health centers plan for resilience

WSS

Readout Newsletter: Nvidia, Biogen, Ionis, AstraZeneca, ChatGPT

Can we make enough H5N1 bird flu vaccine if there's a pandemic?

When prostate cancer spreads, where it goes matters

Philips to halt sales of sleep apnea machines in U.S.

Humana’s losses in Medicare Advantage tank its stock

Readout Newsletter: CG Oncology IPO, Eli Lilly, Tesla, Merck

entertainment

entertainment

explore

Tori Bowie and the unacceptable rates of Black maternal death

Readout Newsletter: Vertex, Pfizer, Kura, and other biotech news

Dobbs anniversary: the lost opportunity of abortion as health care

Bird flu: Don't repeat Covid's 'health versus the economy' framing

Jerome Adams on the need for new antivirals for Covid

Case highlights the risks of experimental stem cell therapy

Drug repurposing or repositioning? The language matters

Wellcome Trust’s new CEO hopes Big Tech gets more involved in public health

What does generative AI mean for health care? We asked experts

FTC sues over Novant Health acquisition of two N.C. hospitals

hotspot

Glen Campbell's doctor discusses his public struggle with Alzheimer's

Wearables generate powerful data but its not useful to doctors, yet

Readout Newsletter: Vertex, Pfizer, Kura, and other biotech news

Humana’s losses in Medicare Advantage tank its stock

Biogen walks away from Aduhelm, years after polarizing approval

White House pharmacy plagued with problems, investigation finds

explore

hotspot

focus

explore